ArticleCancer immunology, immunotherapy : CII2024

Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study.

Guozhen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.